An Emerging Entity: Pancreatic Adenocarcinoma Associated with a Known BRCA Mutation: Clinical Descriptors, Treatment Implications, and Future Directions

BACKGROUND. BRCA1 and BRCA2 germline mutations are associated with an elevated risk for pancreas adenocarcinoma (PAC). Other BRCA-associated cancers have been shown to have greater sensitivity to platinum and poly(ADP-ribose) polymerase (PARP) inhibitors with better clinical outcomes than in sporadi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Lowery, Maeve A., Kelsen, David P., Stadler, Zsofia K., Yu, Kenneth H., Janjigian, Yelena Y., Ludwig, Emmy, D'Adamo, David R., Salo-Mullen, Erin, Robson, Mark E., Allen, Peter J., Kurtz, Robert C., O'Reilly, Eileen M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AlphaMed Press 2011
Onderwerpen:
Gastrointestinal Cancer
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228075/
https://ncbi.nlm.nih.gov/pubmed/21934105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0185
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items